Lilly Research Award Program Recipients
Select Award Recipients Include:
David Timm, Ph.D., Research Advisor
Nickolay Chirgadze, Ph.D., Chief Executive Officer – X-Chip Technologies, Inc.
Designing and developing a device capable of streamlining crystallization, inspection and X-Ray data acquisition in a high capacity format suitable for mail-in crystallography.
Scott May, Ph.D., Senior Research Advisor
Clark Landis, Ph.D., Professor, University of Wisconsin
Application of novel continuous processing technologies and integrated process analytical technologies to expand the use and utility of the asymmetric hydroformylation reaction.
Jeremy Graff Ph.D., Senior Research Advisor
Jerry Pelletier, Ph.D. and Nahum Sonenberg, Ph.D., Professors - McGill University
Defining the eIF4E: mRNA “cap” interaction using virtual screening in silico combined with homogeneous screening to develop putative inhibitors of this interaction as tools useful in establishing the regulation of mRNA translatability in cancer cells.
Michael Knierman, Ph.D., Senior Research Scientist
Norman Dovichi, Ph.D., Professor – University of Notre Dame
Developing capillary electrophoresis – mass spectrometry separation techniques for antibodies and large proteins using top-down proteomics methods.
Joseph T. Brozinick, Ph.D., Research Advisor
Jeffrey Elmendorf, Ph.D., Assistant Professor – Indiana University School of Medicine
Studying the antidiabetic, tissue cholesterol-lowering action of trivalent chromium in mice fed a high-fat diet to explore the functional links between increased hexosamine biosynthesis pathway-mediated de novo cholesterol biosynthesis, plasma membrane cholesterol accumulation, and GLUT4 dysregulation in adipose tissue and skeletal muscle insulin resistance.
Elaine Conner Ph.D., Research Advisor
Robert Rickert, Ph.D., Professor – Sanford Burnham Medical Research Institute
Elucidating the functional signaling nodes and crosstalk in normal, pre-lymphoma and transformed B-cells using mass cytometry, CyTOFTM, and studying the diverse signaling dynamics in response to kinase inhibition in B-cell phenotypes, in vitro and in vivo.